Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $927.68 thousand as of April 29, 2026. Its market cap has decreased by -98.38% in one year.

Market Cap

927.68K

Enterprise Value

23.55M

Revenue

65.09M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 927.68K, a decrease of -99.92%. That is a compound annual growth rate of -47.99%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	927.68K	-86.54%
Dec 31, 2025	6.89M	-95.00%
Dec 31, 2024	137.84M	-23.47%
Dec 29, 2023	180.11M	-24.70%
Dec 30, 2022	239.19M	-59.17%
Dec 31, 2021	585.77M	-29.79%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sirona Biochem	1.35M
Lyra Therapeutics	1.33M
Enzolytics	1.45M
Neon Bloom	1.46M
inTerra Resources	1.47M
CERo Therapeutics Holdings	1.21M
International Stem Cell	1.16M
Windtree Therapeutics	1.15M

Market Cap Rankings